Literature DB >> 8137338

Pharmacokinetic principles of locoregional chemotherapy.

D J Kerr1, G Los.   

Abstract

The rationale for regional chemotherapy is based on the premise that certain tumours are confined to compartments within the body for a large part of their natural history and that the dose-response curves for most cytotoxic drugs are steep. If the drug can be introduced locally, then much higher drug concentrations can be achieved at the site of bulk tumour and the prospects of drug induced cytotoxicity enhanced. The general pharmacokinetic principle guiding regional chemotherapy is that the rate of drug clearance from the local compartment (peritoneal and pleural cavities, vascular territories) is smaller than total body clearance, creating a concentration differential in favour of the local compartment harbouring the majority of the cancer. There is good evidence, under certain situations, that pharmacokinetic advantage can translate to clinical advantage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8137338

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  9 in total

1.  Pneumonitis complicating selective intra-arterial chemotherapy for locally advanced breast carcinoma.

Authors:  A D McLean; J C Doughty; A W Reid; D H McCarter; E Kane; C S McArdle
Journal:  Postgrad Med J       Date:  1996-02       Impact factor: 2.401

2.  Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics.

Authors:  Max Tsai; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Control Release       Date:  2013-09-20       Impact factor: 9.776

Review 3.  Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.

Authors:  Jessie L-S Au; Ze Lu; M Guillaume Wientjes
Journal:  AAPS J       Date:  2015-06-19       Impact factor: 4.009

Review 4.  Intraperitoneal therapy for peritoneal cancer.

Authors:  Ze Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

5.  Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer.

Authors:  Ze Lu; Max Tsai; Dan Lu; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  J Pharmacol Exp Ther       Date:  2008-09-09       Impact factor: 4.030

6.  Novel mouse models of hepatic artery infusion.

Authors:  Minhyung Kim; Daniel T Fisher; Colin A Powers; Emmanuel M Gabriel; Alexis M Korman; Sandra Sexton; Andrei V Gudkov; Joseph J Skitzki
Journal:  J Surg Res       Date:  2017-06-21       Impact factor: 2.192

7.  A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks.

Authors:  Minhyung Kim; Colin A Powers; Leslie I Curtin; Daniel T Fisher; Sandra Sexton; Katerina V Gurova; Joseph J Skitzki; Renuka V Iyer
Journal:  J Surg Res       Date:  2020-03-03       Impact factor: 2.192

8.  Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.

Authors:  G Los; f A Blommaert; R Barton; D D Heath; L den Engelse; C Hanchett; D Vicario; R Weisman; K T Robbins; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution.

Authors:  D J Kerr; A M Young; J P Neoptolemos; M Sherman; P Van-Geene; A Stanley; D Ferry; J W Dobbie; B Vincke; J Gilbert; D el Eini; N Dombros; G Fountzilas
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.